Shiraoka, Japan

Keiichiro Otsuka

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Tokyo University of Pharmacy & Life Sciences. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiichiro Otsuka. Retrieved from https://idiyas.com/inventor/keiichiro-otsuka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiichiro Otsuka: Innovator in Nucleic Acid Delivery Systems

Introduction

Keiichiro Otsuka is a prominent inventor based in Shiraoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of compositions for delivering nucleic acids. His work aims to enhance the efficacy and safety of nucleic acid drugs.

Latest Patents

Otsuka holds a patent for a composition designed for delivering nucleic acids. This innovative composition ensures the stability of nucleic acid drugs, achieves a high intracellular introduction rate, and efficiently expresses the function of the nucleic acid while maintaining low cytotoxicity. The patent discloses a composition that includes a block copolymer with a polyethylene glycol segment linked to a hydrophobic polyester segment, along with a peptide containing 4 to 30 residues, which includes at least one amino acid selected from arginine and lysine.

Career Highlights

Keiichiro Otsuka is affiliated with the Tokyo University of Pharmacy & Life Sciences, where he continues to advance research in the field of drug delivery systems. His work is pivotal in addressing the challenges associated with nucleic acid therapeutics.

Collaborations

Otsuka collaborates with notable colleagues, including Takanori Kanazawa and Yuuki Takashima. Their combined expertise contributes to the advancement of innovative solutions in biotechnology.

Conclusion

Keiichiro Otsuka's contributions to nucleic acid delivery systems represent a significant advancement in biotechnology. His innovative approaches have the potential to improve the effectiveness of nucleic acid-based therapies, paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…